Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Clinical trial NCT00591123 · COMPLETED

Trial details

NCT number: NCT00591123
Sponsor: Translational Oncology Research International
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Unresectable Adenocarcinoma of the Esophagus Metastatic Adenocarcinoma of the Esophagus Unresectable Adenocarcinoma of Gastric Cardia Metastatic Adenocarcinoma of Gastric Cardia

Start date: 2007-12-01
Primary completion: 2011-06-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.